Notifiable Share Interest in Theravance, Inc.

RNS Number : 4880R

GlaxoSmithKline PLC

03 November 2011

 



Notifiable Share Interest in Theravance, Inc.

GlaxoSmithKline plc ("GSK") announces that on 1 November 2011 GSK purchased 58,411 shares of Common Stock of Theravance, Inc. ("Theravance") at a price of $22.23 per share, for a total investment of $1,298,476.53. These shares were purchased from Theravance pursuant to GSK's right to acquire, on a quarterly basis, sufficient shares of common stock to maintain its ownership percentage in Theravance, taking into account the preceding quarter's net option exercise and equity vesting activity.

GSK's interest in Theravance now comprises 15,725,953 shares of Common Stock, which represents approximately 19.01% of Theravance's outstanding capital stock. The calculation is based on a total of 82,666,224 shares of Common Stock   outstanding in Theravance as at 30 September 2011. This purchase is disclosable and will be reported under the rules of the Securities and Exchange Commission.

Victoria Whyte

Company Secretary

3 November 2011

 

END

 

 

HOLLLFFTLSLVIIL